CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and a tumor marker for anaplastic large cell lymphoma. From Wikipedia
CD30 Innovations
Breakthroughs in CD30-targeted therapies are reshaping treatment landscapes for lymphoma and resistant skin cancers.
